Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M556Revenue (TTM) $M69.4Net Margin (%)15.6Altman Z-Score1.5
Enterprise Value $M466EPS (TTM) $0.2Operating Margin %18.9Piotroski F-Score6
P/E(ttm)52.8Beneish M-Score1.6Pre-tax Margin (%)18.1Higher ROA y-yY
Price/Book5.310-y EBITDA Growth Rate %--Quick Ratio9.1Cash flow > EarningsY
Price/Sales8.05-y EBITDA Growth Rate %--Current Ratio9.1Lower Leverage y-yN
Price/Free Cash Flow37.5y-y EBITDA Growth Rate %--ROA % (ttm)7.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)11.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M70.2ROIC % (ttm)81.6Gross Margin Increase y-yN

Gurus Latest Trades with PGNX

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

PGNX is held by these investors:



PGNX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Broadfin Healthcare Master Fun10% Owner 2017-02-15Sell602,600$9.66-18.01view
Broadfin Healthcare Master Fun10% Owner 2017-02-09Sell351,300$9.71-18.43view
ISRAEL ROBERT JExecutive Vice President, Medi 2015-06-11Sell2,000$6.8315.96view
ISRAEL ROBERT JExecutive Vice President, Medi 2015-03-13Sell3,000$713.14view
ISRAEL ROBERT JExecutive Vice President, Medi 2015-03-11Sell2,000$6.8315.96view
ISRAEL ROBERT JExecutive Vice President, Medi 2015-03-03Sell5,000$6.4922.03view
ISRAEL ROBERT JExecutive Vice President, Medi 2015-01-12Sell2,000$7.0612.18view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-12-11Sell3,000$7.0712.02view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-11-21Sell9,000$713.14view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-11-13Sell10,000$6.8315.96view

Press Releases about PGNX :

Quarterly/Annual Reports about PGNX:

News about PGNX:

Articles On GuruFocus.com
Progenics Pharmaceuticals Sets First Quarter 2017 Financial Results Call for May 4 Apr 27 2017 
Progenics Pharmaceuticals Announces Presentations at the 2017 American Society of Clinical Oncology Apr 20 2017 
Progenics Pharmaceuticals Announces Positive Topline Results from Registrational Phase 2b Trial of A Mar 30 2017 
Progenics Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference Mar 30 2017 
Data from Phase 2 Study of Progenics’ PSMA-Targeted Imaging Agent 1404 Published in Journal of Mar 24 2017 
Tiger Management’s Julian Robertson Buys Alibaba, eBay, MasTec, Sells Tableau Software, Monsanto, Nov 14 2014 
Ex-Boxer Paul Tudor Jones Delivering Knockout Punches on Wall Street Nov 07 2014 
Weekly CEO Buys Highlight: CVRR, HBAN, VVTV, SXCP, PGNX Jan 27 2013 
Weekly CEO Buys Highlight: SUSP, ROVI, ZLC, MDW, PGNX Oct 01 2012 
5 Stocks That Dropped the Most Since Gurus Bought Them Sep 13 2012 

More From Other Websites
Progenics Pharmaceuticals Sets First Quarter 2017 Financial Results Call for May 4 Apr 27 2017
Chemed's (CHE) Earnings and Revenues Beat Estimates in Q1 Apr 27 2017
ETFs with exposure to Progenics Pharmaceuticals, Inc. : April 25, 2017 Apr 25 2017
Progenics Pharmaceuticals Announces Presentations at the 2017 American Society of Clinical Oncology... Apr 20 2017
What Poker Taught Me About Investing Apr 02 2017
Progenics Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference Mar 30 2017
Progenics Azedra Succeeds in Mid-Stage Trials Mar 30 2017
Progenics Pharmaceuticals Announces Positive Topline Results from Registrational Phase 2b Trial of... Mar 30 2017
Data from Phase 2 Study of Progenics’ PSMA-Targeted Imaging Agent 1404 Published in Journal of... Mar 24 2017
Progenics Pharmaceuticals, Inc. :PGNX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17,... Mar 17 2017
Progenics Pharmaceuticals, Inc. :PGNX-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017 Mar 14 2017
Progenics reports 4Q loss Mar 09 2017
Progenics Pharmaceuticals Announces Fourth Quarter and Full-Year 2016 Financial Results and... Mar 09 2017
Progenics Pharmaceuticals (PGNX) in Focus: Stock Gains 8.3% Feb 28 2017
Progenics Pharmaceuticals Sets Fourth Quarter and Year-End 2016 Financial Results Call for March 9 Feb 23 2017
Biotech Premarket Movers: Progenics, Alexion, BioCryst Feb 16 2017
Progenics Pharmaceuticals and Shutterfly to Join S&P SmallCap 600 Feb 15 2017
Progenics Pharmaceuticals Announces Initiation of a Phase 1 Clinical Trial of its PSMA-Targeted... Feb 14 2017
Progenics Pharmaceuticals, Inc. to Participate in February Investor Conferences Feb 08 2017
Progenics Pharmaceuticals, Inc. – Value Analysis (NASDAQ:PGNX) : January 30, 2017 Jan 30 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)